title: Aldosterone antagonist decreases blood pressure and improves metabolic parameters in obese patients with the metabolic syndrome.
authors.forename: Monica Barros
authors.initials: MB
authors.lastname: Costa
authors.forename: Danielle Guedes
authors.initials: DG
authors.lastname: Andrade Ezequiel
authors.forename: Julio Cesar
authors.initials: JC
authors.lastname: Morais Lovis
authors.forename: Manoel Marques
authors.initials: MM
authors.lastname: Oliveira
authors.forename: Rogerio
authors.initials: R
authors.lastname: Baumgratz de Paula
mesh_terms: D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D024821:Metabolic Syndrome / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D013148:Spironolactone / Q000494:pharmacology* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone